GBP75000 - GBP90000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose...
Vous n'êtes pas connecté
GBP34000 - GBP40000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new Abingdon, England, Oxfordshire / Oxfordshire, England, Didcot / Oxfordshire, England, Oxford
GBP75000 - GBP90000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose...
Cartesian Therapeutics, Inc, a clinical─stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first...
GAITHERSBURG, Md., July 02, 2024. artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell...
PRINCETON, N.J., July 9, 2024 /PRNewswire/ -- Soligenix, Inc., (Soligenix or the Company), a late-stage biopharmaceutical company focused on...
To define: Oxford BioMedica (UK) Limited: Job description: We want you to feel inspired every day. We’re future-focused and our business is...
Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...
Each year, approximately 100 people are diagnosed with mantle cell lymphoma. Research indicates that these patients are more susceptible to other...
Immutep Limited (Immutep), a clinical─stage biotechnology company developing novel LAG─3 immunotherapies for cancer and autoimmune disease,...
Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...
Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide, a leading global contract research organization (CRO), works in partnership...